Article FDA Thank You FDA updates guidance on developing drugs for Covid-19, replacing pandemic-era version
Agency IQ
DECEMBER 1, 2023
That guidance, first issued in May 2020 , was released at a time when there were no FDA-approved drugs to treat Covid-19, and the standard-of-care for treatment relied on clinical management of symptoms and supportive care (e.g., supplemental oxygen, mechanical ventilation). drug-drug interactions) and intrinsic factors (e.g.,
Let's personalize your content